{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:12:25Z","timestamp":1767849145010,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.05.014","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T23:44:56Z","timestamp":1369179896000},"page":"4024-4032","source":"Crossref","is-referenced-by-count":34,"title":["Cost-effectiveness of hepatitis B vaccination using HEPLISAV\u2122 in selected adult populations compared to Engerix-B\u00ae vaccine"],"prefix":"10.1016","volume":"31","author":[{"given":"Renee Kim","family":"Kuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Heyward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Nordyke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.05.014_bib0005","unstructured":"Centers for Disease Control. Recommendation of the Immunization Practices Advisory Committee (ACIP) Inactivated Hepatitis B Virus Vaccine. MMWR Morb Mortal Wkly Rep 1982;31(24)."},{"key":"10.1016\/j.vaccine.2013.05.014_bib0010","unstructured":"Centers for Disease Control. Hepatitis B Virus: A comprehensive strategy for eliminating transmission in the United States through universal Childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991;40."},{"issue":"May (3)","key":"10.1016\/j.vaccine.2013.05.014_bib0015","article-title":"Surveillance for acute viral hepatitis \u2013 United States, 2007","volume":"58","author":"Daniels","year":"2009","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0020","unstructured":"Centers for Disease Control and Prevention. Disease Burden from Viral Hepatitis A, B, and C in the United States. Available at: http:\/\/www.cdc.gov\/hepatitis\/hbv\/statisticshbv.htm; 2011 [accessed 01.04.13]."},{"key":"10.1016\/j.vaccine.2013.05.014_bib0025","unstructured":"Centers for Disease Control. Adult Vaccination Coverage \u2013 United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61(04):66\u201372."},{"key":"10.1016\/j.vaccine.2013.05.014_bib0030","doi-asserted-by":"crossref","unstructured":"Nelson JC, Bittner RC, Bounds L, Zhao S, Baggs J, Donahue JG, et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. Am J Public Health 2009 October;99 Suppl. 2:S389\u2013S397.","DOI":"10.2105\/AJPH.2008.151332"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.05.014_bib0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.olq.0000258306.20287.a7","article-title":"B vaccination of men who have sex with men attending an urban STD clinic: impact of an ongoing vaccination program, 1998\u20132003","volume":"34","author":"Gunn","year":"2007","journal-title":"Sex Transm Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.05.014_bib0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1258\/ijsa.2007.007136","article-title":"Predictors of first and second dose acceptance of hepatitis B vaccine among STD clinic patients","volume":"19","author":"Zimet","year":"2008","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0045","unstructured":"Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006 December 8;55(RR-16)."},{"issue":"November (50)","key":"10.1016\/j.vaccine.2013.05.014_bib0050","doi-asserted-by":"crossref","first-page":"9316","DOI":"10.1016\/j.vaccine.2011.10.011","article-title":"Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities","volume":"29","author":"Tohme","year":"2011","journal-title":"Vaccine"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.05.014_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-3797(98)00003-8","article-title":"Immunogenicity of hepatitis B vaccines implications for persons at occupational risk of hepatitis B virus infection","volume":"15","author":"Averhoff","year":"1998","journal-title":"Am J Prev Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.05.014_bib0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2337\/diacare.20.2.148","article-title":"Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen","volume":"20","author":"Douvin","year":"1997","journal-title":"Diabetes Care"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2013.05.014_bib0065","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jmv.1890350313","article-title":"A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls","volume":"35","author":"Wismans","year":"1991","journal-title":"J Med Virol"},{"issue":"December (22)","key":"10.1016\/j.vaccine.2013.05.014_bib0070","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1001\/jama.1985.03360220053027","article-title":"Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine","volume":"254","author":"Weber","year":"1985","journal-title":"JAMA"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.05.014_bib0075","first-page":"800","article-title":"Vaccination and chronic kidney disease","volume":"23","author":"Janus","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"March (15)","key":"10.1016\/j.vaccine.2013.05.014_bib0080","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.vaccine.2012.01.087","volume":"30","author":"Halperin","year":"2012","journal-title":"Vaccine"},{"issue":"March (16)","key":"10.1016\/j.vaccine.2013.05.014_bib0085","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.vaccine.2012.02.001","article-title":"Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine","volume":"30","author":"Sablan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0090","doi-asserted-by":"crossref","unstructured":"Janssen RS, Bennett S, Xie F, Heyward WL, Martin JT. Immunogenicity of Two Doses of Investigational HEPLISAV\u2122 Compared to Three Doses of a Licensed Hepatitis B Vaccine (ENGERIX-B\u00ae) in Adults from Two Pivotal, Phase 3 Trials. 2012 October 20; 2012.","DOI":"10.1016\/S0168-8278(13)61425-7"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0095","unstructured":"Centers for Disease Control. Hepatitis B Epidemiology and Prevention of Vaccine-Preventable Diseases, The pink book: course textbook \u2013 12th Ed. Second Printing. Available at: http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/hepb.html; 2012 [accessed 11.07.12]."},{"key":"10.1016\/j.vaccine.2013.05.014_bib0100","unstructured":"Janssen RS, Rahman S, Namini H, Heyward WL, Martin JT. Immunogenicity of investigational HEPLISAV compared with licensed hepatitis B vaccine (Engerix-B) in patients with chronic kidney disease (CKD) and additional factors that reduce immune response to vaccine (PUB134). 2012 October 30; 2012."},{"key":"10.1016\/j.vaccine.2013.05.014_bib0105","unstructured":"Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. Distribution of Age at Diagnosis of Diabetes Among Adult Incident Cases Aged 18\u201379 Years, United States, 1980\u20132008. Available at: http:\/\/www.cdc.gov\/diabetes\/statistics\/age\/fig2.htm; 2010 [accessed 14.09.12]."},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.05.014_bib0110","article-title":"Risk and burden associated with the acquisition of viral hepatitis A and B in the corporate traveler","volume":"50","author":"Bunn","year":"2008","journal-title":"J Occup Environ Med"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2013.05.014_bib0115","article-title":"Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals","volume":"24","author":"Landrum","year":"2010","journal-title":"AIDS"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.05.014_bib0120","article-title":"National surveillance of dialysis-associated diseases in the United States, 2002","volume":"18","author":"Finelli","year":"2005","journal-title":"Semin Dial"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0125","article-title":"Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes","author":"Hoerger","year":"2012","journal-title":"Diabetes Care"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2013.05.014_bib0130","article-title":"B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination","volume":"24","author":"Bauer","year":"2006","journal-title":"Vaccine"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2013.05.014_bib0135","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose","volume":"200","author":"McMahon","year":"2009","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.014_bib0140","doi-asserted-by":"crossref","DOI":"10.1159\/000168436","article-title":"Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients","volume":"12","author":"Buti","year":"1992","journal-title":"Am J Nephrol"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2013.05.014_bib0145","article-title":"Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination","volume":"68","author":"Tsouchnikas","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0150","unstructured":"Centers for Disease Control. Hepatitis B vaccination coverage among adults--United States, 2004. MMWR Morb Mortal Wkly Rep 2006 May 12;55(18)."},{"issue":"September (5)","key":"10.1016\/j.vaccine.2013.05.014_bib0155","article-title":"Hepatitis B risks and immunization coverage among American travelers","volume":"13","author":"Connor","year":"2006","journal-title":"J Travel Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.05.014_bib0160","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archinte.1979.03630390036015","article-title":"Duration of hepatitis B surface antigenemia (HBs Ag) in hemodialysis patients","volume":"139","author":"Ribot","year":"1979","journal-title":"Arch Intern Med"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.05.014_bib0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ki.1977.78","article-title":"Host responses to hepatitis B infection in patients in a chronic hemodialysis unit","volume":"12","author":"London","year":"1977","journal-title":"Kidney Int"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0170","unstructured":"Centers for Disease Control. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Morb Mortal Wkly Rep 1991;50(RR5):1\u201343."},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.05.014_bib0175","article-title":"Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B","volume":"17","author":"Crowley","year":"2000","journal-title":"Pharmacoeconomics"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.05.014_bib0180","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.05.014_bib0185","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.amepre.2006.01.017","article-title":"Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites","volume":"30","author":"Kim","year":"2006","journal-title":"Am J Prev Med"},{"issue":"May (5 Suppl.)","key":"10.1016\/j.vaccine.2013.05.014_bib0190","article-title":"Epidemiology of hepatitis B in the United States","volume":"49","author":"Kim","year":"2009","journal-title":"Hepatology"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.05.014_bib0195","article-title":"Acute liver failure: summary of a workshop","volume":"47","author":"Lee","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0200","article-title":"Adults with diabetes and hepatitis b information requested by ACIP","author":"Murphy","year":"2010","journal-title":"NCHHSTP CDC Presentation"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.05.014_bib0205","article-title":"Development of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen","volume":"7","author":"Tong","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.05.014_bib0210","article-title":"Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm","volume":"15","author":"Ulcickas","year":"2008","journal-title":"J Viral Hepat"},{"issue":"January (Suppl. 1)","key":"10.1016\/j.vaccine.2013.05.014_bib0215","article-title":"Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis","volume":"43","author":"Villa","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2013.05.014_bib0220","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2013.05.014_bib0225","article-title":"Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis","volume":"142","author":"Kanwal","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0230","unstructured":"Centers for Disease Control. United States Life Tables, 2006. 2006. Report No.: National Vital Statistics Reports 2010;58(21)."},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.05.014_bib0235","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0240","unstructured":"United States Renal Data System. Annual Report United States Renal Data System. Available at: http:\/\/www.usrds.org; 2010 [accessed 13.06.11]."},{"issue":"September (6)","key":"10.1016\/j.vaccine.2013.05.014_bib0245","article-title":"Economic methods for measuring the quality of life associated with HIV infection","volume":"8","author":"Bayoumi","year":"1999","journal-title":"Qual Life Res"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2013.05.014_bib0250","article-title":"Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 preference-based SF-6D in chronic kidney disease","volume":"12","author":"Davison","year":"2009","journal-title":"Value Health"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.05.014_bib0255","article-title":"A study of the quality of life and cost-utility of renal transplantation","volume":"50","author":"Laupacis","year":"1996","journal-title":"Kidney Int"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2013.05.014_bib0260","article-title":"The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons","volume":"11","author":"Levy","year":"2008","journal-title":"Value Health"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.05.014_bib0265","article-title":"Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories","volume":"28","author":"Dale","year":"2008","journal-title":"Med Decis Making"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.05.014_bib0270","article-title":"Utilities should not be multiplied: evidence from the preference-based scores in the United States","volume":"46","author":"Fu","year":"2008","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2013.05.014_bib0275","unstructured":"Centers for Disease Control. CDC Vaccine Price List. Available at: http:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/cdc-vac-price-list.htm; 2011 [accessed 13.06.11]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T21:11:57Z","timestamp":1563052317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13005926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":55,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13005926"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}